CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 134 enrolled
Drug / intervention
PinPointe FootLaserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00935649
NCT00935649Phase 3Completed

Multi-Center Trial: Evaluation of PinPointe FootLaser Treatment for Infected Toenails (Onychomycosis)

PathoLase, Inc.·interventional·Posted Jul 9, 2009·Updated Apr 9, 2013

In Brief

A Phase 3 clinical trial evaluating PinPointe FootLaser for Infected Toenails and Onychomycosis. Completed, enrolled 134 participants across 4 sites in 2 countries.

Detailed Summary

To evaluate the safety and efficacy of the PathoLase FootLaser treatment of infected toenails.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada, United States
Collaborators--

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 9, 2009
Enrollment StartJun 1, 2009
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 17.0 years ago

Interventions

PinPointe FootLaserdevice

Medical laser